Mankind Pharma IPO to begin on April 25; closes on April 27

Mankind Pharma, India’s fourth supreme pharmaceutical firm in phrases of home sales and second supreme in phrases of sales volume for the monetary twelve months 2022, will birth for subscription on April 25 and shut on April 27. The anchor bidding will open on 24 April.

April 18, 2023 / 06:34 AM IST

IPO

IPO

Mankind Pharma, India’s fourth supreme pharmaceutical firm in phrases of home sales and second supreme in phrases of sales volume for the monetary twelve months 2022, will birth for subscription on April 25 and shut on April 27. The anchor bidding will open on April 24.

Credit of equity shares will more than likely be on Might perchance perhaps 8 and the stock will more than likely be listed on exchanges on Might perchance perhaps 9.

The IPO consists of a pure offer on the market of upto 40.06 million shares by its existing shareholders and promoters. The OFS contains upto 3.71 million shares by Ramesh Juneja, upto 3.51 million shares by Rajeev Juneja, 2.80 million shares by Sheetal Arora, upto 17.41 million by Cairnhill CIPEF Ltd2, upto 2.62 million shares by Cairnhill CGPE Ltd, upto 9.96 million shares by Beige Ltd, and upto 50,000 shares by Hyperlink Investment Belief.

Mankind Pharma, which manufactures the accepted condom ticket Manforce Condoms, pregnancy check kit Prega News, and emergency contraceptive ticket Unwanted-72, is supported by personal equity firm Chrys Capital and Capital World. Ramesh Juneja founded the firm, which became a fully integrated pharmaceutical firm in 1995. It develops, manufactures, and markets a various fluctuate of pharmaceutical formulations across a form of acute and power therapeutic areas, as well to a unfold of particular person healthcare products.

Also Study: Chrys Capital-backed Mankind Pharma might perhaps perhaps well also waft Rs 4,200-4,700 crore IPO in April

Mankind Pharma has a solid focal point on the home market, with income from operations in India accounting for 97.60 p.c of its total income within the monetary twelve months 2022. The firm has developed 36 brands within the pharmaceutical commercial and boasts one in every of the supreme networks of clinical representatives within the Indian pharmaceutical market.

Moreover its accepted Manforce Condoms, Prega News, and Unwanted-72 brands, Mankind Pharma has additionally established a unfold of particular person healthcare brands in classes reminiscent of antacid powders (Gasoline-O-Quick), vitamin and mineral supplements (Successfully being OK ticket), and anti-acne preparations (AcneStar ticket), among others.

Kotak Mahindra Capital, Jefferies, IIFL Capital, Axis Capital, and JP Morgan are the lead managers to the IPO. Meanwhile, Shardul Amarchand Mangaldas, Cyril Amarchand Mangaldas, AZB & Partners, and Sidley Austin are the legislation companies fascinated by the deal.

Study Extra

Website Designed & SEO done by KV TechMedia - Web Design Company Uttar Pradesh, India
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram